Smartleaf Asset Management’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.5K Hold
1,606
﹤0.01% 1856
2026
Q1
$26.2K Sell
1,606
-1,264
-44% -$19.8K ﹤0.01% 1812
2025
Q4
$42.9K Buy
2,870
+788
+38% +$11.1K ﹤0.01% 1628
2025
Q3
$26K Buy
2,082
+113
+6% +$1.51K ﹤0.01% 1699
2025
Q2
$30.1K Sell
1,969
-556
-22% -$8.67K ﹤0.01% 1381
2025
Q1
$42.4K Buy
2,525
+229
+10% +$4.21K ﹤0.01% 1233
2024
Q4
$43.2K Buy
2,296
+769
+50% +$14.8K ﹤0.01% 1242
2024
Q3
$28.5K Buy
1,527
+356
+30% +$6.82K ﹤0.01% 1145
2024
Q2
$22.1K Buy
1,171
+679
+138% +$11.6K ﹤0.01% 998
2024
Q1
$7.8K Buy
+492
New +$7.2K ﹤0.01% 1082

Other funds holding SEM

Smartleaf Asset Management's SEM Position: Q2 2026 in Review

Smartleaf Asset Management held its Select Medical (SEM) position steady in Q2 2026 at 1,606 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

Smartleaf Asset Management first reported a position in SEM in Q1 2024 and has held it in 10 quarters since. The position peaked at $43.2K in Q4 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Smartleaf Asset Management held 1,606 shares of Select Medical worth $26.5K as of Q2 2026.
  • Smartleaf Asset Management left its Select Medical share count unchanged in Q2 2026.
  • Select Medical made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1856 holding.
  • Smartleaf Asset Management first reported a position in Select Medical in Q1 2024 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Select Medical position peaked at $43.2K in Q4 2024.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.